Multiple Sclerosis

Definition: A chronic autoimmune disorder affecting the central nervous system (CNS), characterized by the immune system attacking the myelin sheath, which insulates nerve fibers.

Types:
RelapsingRemitting MS (RRMS):
Characterized by episodes of worsening symptoms (relapses) followed by periods of recovery (remission).
Secondary Progressive MS (SPMS): Follows an initial relapsingremitting course, leading to a gradual worsening of symptoms.
Primary Progressive MS (PPMS): Involves a gradual onset and continuous progression of symptoms without clear relapses.
ProgressiveRelapsing MS (PRMS): A rare form that shows progressive symptoms from the onset with occasional relapses.

Symptoms:
Physical:
Fatigue, muscle weakness, difficulty walking, and coordination issues.
Sensory: Numbness, tingling, and altered sensations.
Cognitive: Problems with memory, attention, and problemsolving.
Emotional: Mood swings, depression, and anxiety.

Causes:
The exact cause is unknown, but factors may include genetic predisposition, environmental triggers, and viral infections.

Diagnosis:
Neurological examination, MRI scans to detect lesions in the CNS, and lumbar puncture (spinal tap) to analyze cerebrospinal fluid.

Treatment Options:
Medications:
Diseasemodifying therapies (DMTs) to slow progression, corticosteroids for relapses, and symptomatic treatments for fatigue, pain, and spasticity.
Rehabilitation: Physical therapy, occupational therapy, and speech therapy to improve quality of life.

Lifestyle Management:

Regular exercise, a balanced diet, stress management, and adequate rest can help manage symptoms and improve overall wellbeing.

Prognosis:
MS varies greatly among individuals; some may experience mild symptoms, while others may have significant disability over time. Early diagnosis and treatment can improve outcomes and quality of life.

 

    Related Conference of Multiple Sclerosis

    February 03-04, 2025

    37th World Conference on Neurology

    London, UK
    February 17-18, 2025

    5th International Conference on Child Neurology

    Aix-en-Provence, France
    February 20-21, 2025

    6th International Conference on Neurologists

    Amsterdam, Netherlands
    February 24-25, 2025

    4th International Conference onAlzheimer and Dementia

    Madrid, Spain
    February 27-28, 2025

    7th World Depression Congress

    Paris, France
    March 10-11, 2025

    8th World Conference on Neuroscience

    Paris, France
    March 13-14, 2025

    7th World Conference on Neuroscience

    Prague, Czech Republic
    March 24-25, 2025

    38th European Neurology Congress 2025

    London, UK
    April 24-25, 2025

    6th World Congress on Sleep Disorders and Therapeutics

    Amsterdam, Netherlands
    April 29-30, 2025

    11th International Conference on Epilepsy & Treatment

    Barcelona, Spain
    May 12-13, 2025

    39th European Neurology Congress

    London, UK
    July 17-18, 2025

    31st Annual Summit on Neuroscience & Neurological Disorders

    Amsterdam, Netherlands
    July 23-24, 2025

    15th Global Alzheimers Summit

    Paris, France
    July 28-29, 2025

    35th World Congress on Neurology and Neuroscience

    Paris, France
    August 25-26, 2025

    20th Annual Congress on Neuroscience

    Aix-en-Provence, France
    September 25-26, 2025

    12th Annual congress on Stroke and Neurological Disorders

    Zurich, Switzerland
    October 20-21, 2025

    7th World Brain Congress

    Osaka, Japan
    October 29-30, 2025

    5th Annual Dementia Congress

    Amsterdam, Netherlands
    November 13-14, 2025

    38th International Conference on Neuroscience and Neurochemistry

    Aix-en-Provence, France
    November 13-14, 2025

    32nd Cognitive Neuroscience Congress

    Bali, Indonesia

    Multiple Sclerosis Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in